Harvest Integrated Research Organization (HiRO)

Exhibitor

Harvest Integrated Research Organization (HiRO) is a modern, full-service global CRO delivering disciplined, end-to-end clinical development solutions for biopharma innovators. With integrated teams, advanced clinical data science, and globally aligned operations, HiRO provides seamless support across the full trial lifecycle, from early strategic planning to regulatory approval and beyond.

HiRO brings deep expertise in oncology and rare disease research, supporting complex, biomarker-driven and multi-regional programs across all phases of development. Its oncology experience spans solid tumors and hematologic malignancies, including rare and orphan indications, while its rare disease capabilities are built around precision execution in small patient populations and highly specialized protocols.

A core strength of HiRO is its ability to design and execute cross-border clinical trials, bridging regions such as the U.S., Asia-Pacific, Europe, and Australia and New Zealand through a unified operational framework and strong global site networks. This approach enables consistent, high-quality execution across regions while ensuring regulatory alignment and efficient study delivery.

By combining global expertise with regionally informed insight, HiRO enables sponsors to navigate complexity with confidence. Accelerating development timelines while maintaining clarity, quality, and regulatory alignment across every stage of the clinical journey.  

As proud sponsors of WODCUS 2026, we invite you to meet with us in Boston at Booth #423, to explore how our rare‑disease expertise can support your next clinical trial.

website